Telmisartan And Hydrochlorothiazide recalls
Telmisartan And Hydrochlorothiazide products have been recalled 2 times, most recently on 17 Aug 2022. The recalling company is usually Glenmark Pharmaceuticals Inc., U.
Total recalls2since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 17 Aug 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why telmisartan and hydrochlorothiazide is recalled
Companies
Product types
By year
All telmisartan and hydrochlorothiazide recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/12.5 mg recalledTelmisartan And Hydrochlorothiazide | Glenmark Pharmaceuticals Inc., U | Other | Nationwide |
| Drug | CLASS II | Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/25 mg recalledTelmisartan And Hydrochlorothiazide | Glenmark Pharmaceuticals Inc., U | Other | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.